|

TSR-042 or Dostarlimab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Dostarlimab

Pipeline

Phase 2: 1

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1

Indications

  • Stage III (Any T, N+)1
  • Clinical Stage: Stage II (T3-4, N-)1
  • Rectal Adenocarcinoma1
  • Solid Tumor1
  • Solid Tumor, Adult1

Hartford, Connecticut1 trial

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Hartford Healthcare (Data Collection)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.